Congress trades and big insider sales, sent the day they're filed. Free.
Open in TelegramOfficers, directors and 10% owners must report trades within two business days on SEC Form 4. INSIDER parses each filing's XML from EDGAR. By default only discretionary open-market purchases and sales are shown; grants, option exercises and tax withholding are one click away.
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 15 | Reich RichardSVP and Gen Counsel | Open-market sale · 10b5-1 plan | SELL | $289K 5,449 sh | Mar 20, 2026 |
| 15 | Wu LeiDirector, Chief Executive Officer, 10% Owner | Open-market sale · 10b5-1 plan | SELL | $1.03M 25.6K sh | Mar 20, 2026 traded Mar 20, 2026 |
| 15 | Beilman KyleCFO and COO and Secretary | Tax withholding | F | $672K 3,261 sh | Mar 20, 2026 traded Mar 18, 2026 |
| 13 | Perez-Tenessa AlejandroDirector | Grant or award | A | — 58 sh | Mar 20, 2026 traded Mar 18, 2026 |
| 13 | Leshinski ScottPresident | Grant or award | A | — 100.0K sh | Mar 20, 2026 traded Mar 19, 2026 |
| 13 | Siegel Ian H.Director, CHIEF EXECUTIVE OFFICER, 10% Owner | Open-market sale · 10b5-1 plan | SELL | $23K 9,722 sh | Mar 20, 2026 traded Mar 19, 2026 |
| 13 | Shlimak AnnaSee Remarks | Option exercise | M | — 28.4K sh | Mar 20, 2026 traded Mar 19, 2026 |
| 13 | Shlimak AnnaSee Remarks | Option exercise | M | — 28.4K sh | Mar 20, 2026 traded Mar 19, 2026 |
| 13 | Schreiber Daniel A.Director, Chief Executive Officer | Grant or award | A | — 180.0K sh | Mar 20, 2026 traded Mar 18, 2026 |
| 13 | Stenberg JonDirector, President & CEO | Option exercise | M | — 45.2K sh | Mar 20, 2026 traded Mar 18, 2026 |
| 13 | Raman PrakashDirector | Grant or award | A | $13K 6,105 sh | Mar 20, 2026 traded Mar 20, 2026 |
| 13 | Mekhalfa SabrinaChief Accounting Officer | Option exercise | M | — 3,577 sh | Mar 20, 2026 traded Mar 18, 2026 |
| 13 | Winkles IsabelleChief Financial Officer | Grant or award | A | — 84.5K sh | Mar 20, 2026 traded Mar 18, 2026 |
| 13 | McColgan Michael JDirector | Grant or award | A | — 100 sh | Mar 20, 2026 traded Mar 18, 2026 |
| 13 | Malik AsthaChief Business Officer | Grant or award | A | — 70.7K sh | Mar 20, 2026 traded Mar 18, 2026 |
| 13 | Malik AsthaChief Business Officer | Grant or award | A | — 117.5K sh | Mar 20, 2026 traded Mar 18, 2026 |
| 13 | Winkles IsabelleChief Financial Officer | Grant or award | A | — 135.2K sh | Mar 20, 2026 traded Mar 18, 2026 |
| 13 | Siegel Ian H.Director, CHIEF EXECUTIVE OFFICER, 10% Owner | Open-market sale · 10b5-1 plan | SELL | $21K 9,722 sh | Mar 20, 2026 traded Mar 20, 2026 |
| 13 | Wu LeiDirector, Chief Executive Officer, 10% Owner | Open-market sale · 10b5-1 plan | SELL | $687K 16.8K sh | Mar 20, 2026 traded Mar 19, 2026 |
| 13 | Wu LeiDirector, Chief Executive Officer, 10% Owner | Open-market sale · 10b5-1 plan | SELL | $448K 10.8K sh | Mar 20, 2026 traded Mar 19, 2026 |
| 13 | Carroll ChristinaDirector | Grant or award | A | — 51.8K sh | Mar 20, 2026 traded Mar 18, 2026 |
| 12 | Herraiz Lizette BenediGENERAL COUNSEL | Open-market sale · 10b5-1 plan | SELL | $238K 2,982 sh | Mar 20, 2026 traded Mar 18, 2026 |
| 12 | Duffy Kristine DDirector | Other acquisition or disposition | J | $7,495 236 sh | Mar 20, 2026 traded Mar 18, 2026 |
| 12 | Robbins Edward Hutchinson Jr.EVP, General Counsel | Tax withholding | F | $216K 50.5K sh | Mar 20, 2026 traded Mar 19, 2026 |
| 12 | Morris Philip CDirector | Other acquisition or disposition | J | $7,495 236 sh | Mar 20, 2026 traded Mar 18, 2026 |
| 12 | Boone Travis JDirector, PRESIDENT & CEO | Tax withholding | F | $109K 10.5K sh | Mar 20, 2026 traded Mar 20, 2026 |
| 12 | Stenberg JonDirector, President & CEO | Tax withholding | F | $55K 11.9K sh | Mar 20, 2026 traded Mar 18, 2026 |
| 12 | Bendza Gary MarkEVP, CFO | Tax withholding | F | $211K 49.5K sh | Mar 20, 2026 traded Mar 19, 2026 |
| 12 | Antonello Katherine H.Director, President & CEO | Tax withholding | F | $205K 5,258 sh | Mar 20, 2026 traded Mar 18, 2026 |
| 12 | Dawsey James MDirector | Other acquisition or disposition | J | $14K 453 sh | Mar 20, 2026 traded Mar 18, 2026 |
| 11 | Dieter DavidEVP & General Counsel | Open-market sale · 10b5-1 plan | SELL | $488K 14.0K sh | Mar 20, 2026 traded Mar 18, 2026 |
| 9 | Peterson CarynEVP, Regulatory Affairs | Disposition to issuer | D | — 22.8K sh | Mar 20, 2026 traded Mar 19, 2026 |
| 9 | Giraudo BryanCOO/CFO | Grant or award | A | — 176.7K sh | Mar 20, 2026 traded Mar 19, 2026 |
| 9 | Aranda RichardChief Medical Officer | Disposition to issuer | D | — 40.0K sh | Mar 20, 2026 traded Mar 19, 2026 |
| 9 | Peterson CarynEVP, Regulatory Affairs | Grant or award | A | — 18.8K sh | Mar 20, 2026 traded Mar 19, 2026 |
| 9 | Peterson CarynEVP, Regulatory Affairs | Grant or award | A | — 32.3K sh | Mar 20, 2026 traded Mar 19, 2026 |
| 9 | Peterson CarynEVP, Regulatory Affairs | Disposition to issuer | D | — 18.8K sh | Mar 20, 2026 traded Mar 19, 2026 |
| 9 | Giraudo BryanCOO/CFO | Grant or award | A | — 693.8K sh | Mar 20, 2026 traded Mar 19, 2026 |
| 9 | You Harry L.Director, 10% Owner | Grant or award | A | — 1.16M sh | Mar 20, 2026 traded Mar 19, 2026 |
| 9 | Brown HaydenDirector, President & CEO | Option exercise | M | — 28.7K sh | Mar 20, 2026 traded Mar 18, 2026 |